about
Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modificationsHigh-dimensional data analysis: selection of variables, data compression and graphics--application to gene expression.Connections between permutation and t-tests: relevance to adaptive methods.Adaptive designs for confirmatory clinical trials.Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach.Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.Author's reply: To PMID 21837623.Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug Administration.Model-based dose finding under model uncertainty using general parametric models.Unbiased estimation of selected treatment means in two-stage trials.Estimation bias in survival data within clinical trials that use adaptive seamless designs.Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major.Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples' by C. R. Mehta and S. J. Pocock.Simultaneous inference for several quantiles of a normal population with applications.A unified framework for weighted parametric multiple test procedures.The contribution of Jürgen Läuter to multivariate statistics.Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.An evaluation of methods for testing hypotheses relating to two endpoints in a single clinical trial.Hierarchical testing of multiple endpoints in group-sequential trials.Letter to the editor "Comment on Qiu and Hwang (2007), Biometrics 63, 767-776".Statistical comparisons of community catabolic profilesAdjusting for selection bias in assessing treatment effect estimates from multiple subgroups
P50
Q28652785-ABE7D8FD-2622-4184-A53E-C2F4AB707366Q33428647-8AB3CB3C-6804-42B2-80C7-B85EF8D02383Q36379731-50A01E29-4F7B-4DA3-B379-3863A044985CQ37389417-68BF49A7-8006-4EB5-BBBF-845BDCD478BCQ39961475-09E5488B-CC05-42C3-8899-20F983010A8EQ42121068-91136D3C-7BD3-4246-B68F-E4C2F39BA3B4Q42321286-005BDACF-3F67-4DAA-B25B-29DFFBF0E68FQ42926244-B4100E6F-8F37-412B-9615-AB39A397465DQ43633505-93B07670-6431-4C21-98A2-E2E2B97E0C3AQ43889519-27B3595C-9EF4-4703-BD94-2EC7DCE95436Q44443386-8A8DB110-0CBE-46FC-82A0-0AF897310815Q45991890-2D57886D-9068-4BD6-A6ED-AA68E1C2BBAFQ46939101-563931C4-392C-48C6-A0CE-E27AE519242AQ47334615-50A6E62D-1793-41EF-AF04-3DC9639DC079Q47940472-36F8C142-E227-4693-A284-5EE5CB6E7101Q48333954-9D442285-26A2-45EC-B937-FFB16F2FA7EAQ48606249-BD7647D6-046C-4ECB-8370-56799EE179A8Q51397243-5710B35C-0E3A-40C9-95A3-118C81EEBF79Q51422640-6A6544E7-EE0A-4BD5-9D3F-8AD1E1232996Q51785165-8970152E-B292-4173-8EED-34FC2FF78FE8Q51843484-F6B19CF0-7B2B-4DCB-88F0-B3C2BCABE203Q57238350-029F78C0-C6D3-42DE-920D-BB3D4858A339Q93358051-CF2097E0-367B-4B34-B6FD-47FA1EC52E51
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ekkehard Glimm
@ast
Ekkehard Glimm
@en
Ekkehard Glimm
@es
Ekkehard Glimm
@nl
type
label
Ekkehard Glimm
@ast
Ekkehard Glimm
@en
Ekkehard Glimm
@es
Ekkehard Glimm
@nl
prefLabel
Ekkehard Glimm
@ast
Ekkehard Glimm
@en
Ekkehard Glimm
@es
Ekkehard Glimm
@nl
P106
P31
P496
0000-0003-3624-961X